MedTrace Logo

Sleep Quality After Stellate-ganglion Block of Patients Undergoing Breast Cancer Operation

NCT02651519 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2017-03-24

No results posted yet for this study

Summary

Stellate-ganglion block have been done safely for more than 60 years. It has proved to provide survivors of breast cancer with relief from hot flushes and sleep dysfunction with few or no side-effects. The aim of the present study is to evaluate postoperative sleep quality of patients undergoing breast cancer surgery with Stellate-ganglion block performed in the operation.

Conditions

  • Sleep Deprivation

Interventions

DRUG

0.25% ropivacaine hydrochloride

stellate-ganglion block with 0.25% ropivacaine hydrochloride

DRUG

saline

stellate-ganglion block with saline

Sponsors & Collaborators

  • China Medical University, China

    lead OTHER

Principal Investigators

  • Wen-fei Tan, PhD,MD · First Hospital of China Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02651519 on ClinicalTrials.gov